Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort.
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F.
Halfon P, et al. Among authors: leroy v.
Antivir Ther. 2018;23(4):307-314. doi: 10.3851/IMP3184.
Antivir Ther. 2018.
PMID: 28730994